查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587505

聚合物生物分析测试服务市场规模、份额、趋势分析报告：2025-2030 年按阶段、测试、类型、治疗领域、最终用途、地区和细分市场预测

Large Molecule Bioanalytical Testing Services Market Size, Share & Trends Analysis Report By Phase (Preclinical, Clinical), By Test (ADME, PD), By Type, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

聚合物生物分析测试服务市场的成长与趋势

Grand View Research, Inc.最新报告显示，预计到2030年，全球聚合物生物分析测试服务市场规模将达37亿美元，2025年至2030年复合年增长率为9.63%。

在生物标记、大分子和其他物质的临床测试中越来越多地使用生物分析测试是该行业的主要驱动力。新兴国家慢性病盛行率的上升和临床检测需求的增加是推动市场成长的因素。例如，根据世界卫生组织的数据，2020 年约有 1,000 万人将死于癌症。根据癌症估计，到 2040 年，可能有 3,020 万人受到癌症的影响。预计推动该细分市场成长的其他因素包括生技药品数量的增加、对先进技术的高需求以及对个人化孤儿药和药品的需求。

此外，技术进步、临床测试全球化以及 CRO 进行临床测试的需求不断增加等因素预计将加速该行业的扩张。然而，由于 COVID-19 大流行，主要製药和生物分析公司遇到了挑战，扰乱了临床研究和治疗。除了 COVID-19计划的工作量（包括启动临床测试、临床前测试、生物分析以及与监管机构的互动）之外，其他挑战还包括现场工人的流失。非新冠病毒倡议被推迟，资源被用于支持新冠病毒检测的生物分析、临床前和临床检测，导致等待时间长达 4-6 个月。我们还必须弄清楚哪些检测与新冠病毒相关，哪些不相关。

聚合物生物分析测试服务市场报告亮点

  • 2024年，临床市场占有率份额，达到66.6%。开发中国家慢性病盛行率的增加和临床检测需求的增加预计将成为推动该领域成长的因素。
  • 全球市场分为药物动力学、抗药抗体（ADA）等。 2024 年，ADA 细分市场在全球市场中占据最大的收益占有率。
  • 2024 年，生物有效性领域占据最大收益占有率。该细分市场的成长是由于学名药製造中对这些服务的高需求。
  • 2024年全球市场中，肿瘤学占大部分收益占有率。预计该细分市场在预测期内的复合年增长率也将是最快的。
  • 2024年，市场区隔将主导全球市场。预计该细分市场将以最快的复合年增长率成长，并在预测期内保持其市场主导地位。
  • 北美聚合物生物分析测试服务市场主导全球市场，2024年收益占有率超过48.94%。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章高分子生物分析测试服务市场的变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 研发投资金筹措视角
  • 临床试验量分析（2023）
  • 定价模式分析
  • 技术景观
  • 聚合物生物分析测试服务市场分析工具
    • 波特五力分析
    • PESTEL分析

第四章 聚合物生物分析测试服务市场：分阶段估计与趋势分析

  • 聚合物生物分析测试服务市场，依阶段：细分仪表板
  • 全球聚合物生物分析测试服务市场分阶段：波动分析
  • 爱别，2018-2030（百万美元）
  • 临床前
    • 有抗体
    • 无抗体（基于 ELISA 的检测）
  • 临床

第五章聚合物生物分析测试服务市场：按类型估计和趋势分析

  • 聚合物生物分析测试服务市场，按类型：细分仪表板
  • 全球聚合物生物分析测试服务市场（按类型）：变异分析
  • 按类型划分，2018-2030（百万美元）
  • 药物动力学
    • 2018-2030年药物动力学市场估计与预测
  • ADA
    • 2018-2030 年 ADA 市场估算与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第六章 聚合物生物分析测试服务市场：依测试类型估算与趋势分析

  • 聚合物生物分析测试服务市场，按测试类型：细分仪表板
  • 按测试类型分類的全球聚合物生物分析测试服务市场：变异分析
  • 按测试类型，2018-2030（百万美元）
  • ADME
  • PD
  • 生物有效性
  • 生物等效性
  • 其他的

第七章 高分子生物分析检测服务市场：依治疗领域估算及趋势分析

  • 聚合物生物分析测试服务市场，按治疗领域：细分仪表板
  • 按治疗领域分類的全球聚合物生物分析测试服务市场：波动分析
  • 按治疗领域，2018-2030 年（百万美元）
  • 肿瘤学
    • 2018-2030 年肿瘤学市场估计与预测
  • 感染疾病
    • 2018-2030年感染疾病市场估计与预测
  • 心臟病
    • 2018-2030年心臟病市场估计与预测
  • 神经病学
    • 2018-2030 年神经病学市场估计与预测
  • 其他的
    • 2018-2030 年其他市场估计与预测

第八章聚合物生物分析测试服务市场：按最终用途分类的估算和趋势分析

  • 聚合物生物分析测试服务市场，依最终用途：细分仪表板
  • 全球聚合物生物分析测试服务市场（按最终用途）：变化分析
  • 按最终用途划分，2018-2030 年（百万美元）
  • 小型企业
    • 2018-2030 年小型企业市场估计与预测
    • 合约研究官（CRO）和首席行销长（CMO）
    • 赞助机构
    • 其他的
  • 大公司
    • 2018-2030年大公司市场估计与预测
    • 合约研究官（CRO）和首席行销长（CMO）
    • 赞助机构
    • 其他的

第九章聚合物生物分析测试服务市场：按地区估算及趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 泰国
    • 韩国
    • 澳洲
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第10章竞争格局

  • 市场分类
  • Market Leaders
  • Emerging Players
  • 2024 年市场分析
  • 公司简介
    • Laboratory Corporation of America Holdings
    • IQVIA
    • Syneous Health
    • SGS, SA
    • WuXi AppTec
    • Intertek Plc
    • Pace Analytical Services LLC
    • ICON PLC
    • Charles River Laboratories
    • ThermoFisher Scientific
Product Code: GVR-4-68038-979-1

Large Molecule Bioanalytical Testing Services Market Growth & Trends:

The global large molecule bioanalytical testing services market size is expected to reach USD 3.70 billion by 2030, registering a CAGR of 9.63% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increased use of bioanalytical testing in clinical trials of biomarkers, large molecules, and other substances is the main driver of the industry. The rising incidence of chronic diseases and the rising demand for clinical trials in developing nations are the factors driving the market growth. For instance, according to the WHO, around 10 million people died from cancer in 2020. As per the estimates of cancer, 30.2 million people are likely to have cancer by 2040. Other factors that are anticipated to drive the segment growth include a rise in biologics, high demand for advanced technologies, and the need for personalized orphan drugs & medicines.

It is also projected that factors like technological advancement, globalization of clinical trials, and the rising need for CROs to perform clinical trials will accelerate industry expansion. Large pharmaceutical and bioanalytical firms, however, encountered difficulties as a result of the COVID-19 pandemic, which hampered clinical studies and treatments. Along with the workload of the COVID-19 project, which involves starting clinical trials, preclinical testing, doing bioanalysis, and interacting with regulatory bodies, other difficulties include the loss of workers at sites. The non-Covid initiatives were delayed, and there were lengthy 4-6 month wait times as a result of the resources being used to support the bioanalytical, preclinical, and clinical testing for the Covid trials. They must also resolve assays that are related to Covid and those that are not.

Large Molecule Bioanalytical Testing Services Market Report Highlights:

  • The clinical phase segment dominated the market in 2024 with the largest revenue share of 66.6%. The growing prevalence of chronic diseases and increasing demand for clinical trials in developing countries are factors expected to drive segment growth.
  • The global market is segmented into pharmacokinetics, Antidrug Antibodies (ADA), and others. The ADA segment accounted for the largest revenue share of the global market in 2024.
  • The bioavailability segment held the largest revenue share in 2024. The segment growth can be attributed to the high demand for these services in generic drug manufacturing.
  • Oncology accounted for a majority of revenue share in the global market in 2024. The segment is also anticipated to register the fastest CAGR during the forecast period.
  • The SMEs segment dominated the global market in 2024. The segment is also anticipated to grow at the fastest CAGR over the forecast timeline, retaining its market dominance.
  • North America large molecule bioanalytical testing services market dominated globally in 2024 with a revenue share of more than 48.94%.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Phase
    • 1.1.2. Type
    • 1.1.3. Test Type
    • 1.1.4. Therapeutic Area
    • 1.1.5. End Use
    • 1.1.6. Regional scope
    • 1.1.7. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Large Molecule Bioanalytical Testing Services Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological advancements in analytical testing
      • 3.2.1.2. Regulatory control and increasing awareness regarding bioanalytical testing
      • 3.2.1.3. Growing R&D expenditure in the pharmaceutical and biopharmaceutical industries
      • 3.2.1.4. Rising demand for outsourcing of analytical testing
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Compliance issues while outsourcing
      • 3.2.2.2. Data security concerns
  • 3.3. R&D Investments & Funding Perspective
  • 3.4. Clinical Trials Volume Analysis, (2023)
  • 3.5. Pricing Model Analysis
  • 3.6. Technology Landscape
  • 3.7. Large Molecule Bioanalytical Testing Services Market Analysis Tools
    • 3.7.1. Porter's Five Forces Analysis
    • 3.7.2. PESTEL Analysis

Chapter 4. Large Molecule Bioanalytical Testing Services Market: Phase Estimates & Trend Analysis

  • 4.1. Large Molecule Bioanalytical Testing Services Market, By Phase: Segment Dashboard
  • 4.2. Global Large Molecule Bioanalytical Testing Services Market by Phase: Movement Analysis
  • 4.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Phase, 2018 - 2030 (USD Million) for the following
  • 4.4. Preclinical
    • 4.4.1. Preclinical market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. With Antibody
      • 4.4.2.1. With Antibody market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Without Antibody (ELISA Based Assay)
      • 4.4.3.1. Without Antibody (ELISA Based Assay) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Clinical
    • 4.5.1. Clinical market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Large Molecule Bioanalytical Testing Services Market by Type Estimates & Trend Analysis

  • 5.1. Large Molecule Bioanalytical Testing Services Market, By Type: Segment Dashboard
  • 5.2. Global Large Molecule Bioanalytical Testing Services Market by Type: Movement Analysis
  • 5.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Type, 2018 - 2030 (USD Million) for the following
  • 5.4. Pharmacokinetics
    • 5.4.1. Pharmacokinetics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. ADA
    • 5.5.1. ADA market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Large Molecule Bioanalytical Testing Services Market: Test Type Estimates & Trend Analysis

  • 6.1. Large Molecule Bioanalytical Testing Services Market, By Test: Segment Dashboard
  • 6.2. Global Large Molecule Bioanalytical Testing Services Market by Test Type: Movement Analysis
  • 6.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Test Type, 2018 - 2030 (USD Million) for the following
  • 6.4. ADME
    • 6.4.1. ADME market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. PD
    • 6.5.1. PD market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Bioavailability
    • 6.6.1. Bioavailability market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Bioequivalence
    • 6.7.1. Bioequivalence market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Other Tests
    • 6.8.1. Other tests market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Large Molecule Bioanalytical Testing Services Market by Therapeutic Area Estimates & Trend Analysis

  • 7.1. Large Molecule Bioanalytical Testing Services Market, By Therapeutic Area: Segment Dashboard
  • 7.2. Global Large Molecule Bioanalytical Testing Services Market by Therapeutic Area: Movement Analysis
  • 7.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By Therapeutic Area, 2018 - 2030 (USD Million) for the following
  • 7.4. Oncology
    • 7.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Infectious Diseases market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Cardiology
    • 7.6.1. Cardiology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.7. Neurology
    • 7.7.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Large Molecule Bioanalytical Testing Services Market by End Use Estimates & Trend Analysis

  • 8.1. Large Molecule Bioanalytical Testing Services Market, By End Use: Segment Dashboard
  • 8.2. Global Large Molecule Bioanalytical Testing Services Market by End Use: Movement Analysis
  • 8.3. Global Large Molecule Bioanalytical Testing Services Market Estimates & Forecasts, By End Use, 2018 - 2030 (USD Million) for the following
  • 8.4. SMEs
    • 8.4.1. SMEs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.2. CROs & CMOs
      • 8.4.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.3. Sponsor Organizations
      • 8.4.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.4.4. Others
      • 8.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 8.5. Large Firms
    • 8.5.1. Large Firms market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.2. CROs & CMOs
      • 8.5.2.1. CROs & CMOs market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.3. Sponsor Organizations
      • 8.5.3.1. Sponsor Organizations market estimates and forecasts, 2018 to 2030 (USD Million)
    • 8.5.4. Others
      • 8.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 9. Large Molecule Bioanalytical Testing Services Market: Regional Estimates & Trend Analysis

  • 9.1. Regional market share analysis, 2024 & 2030
  • 9.2. Regional Market Dashboard
  • 9.3. North America
    • 9.3.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.2. U.S.
      • 9.3.2.1. Key Country Dynamics
      • 9.3.2.2. Competitive Scenario
      • 9.3.2.3. Regulatory Framework
      • 9.3.2.4. U.S. large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.3. Canada
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Competitive Scenario
      • 9.3.3.3. Regulatory Framework
      • 9.3.3.4. Canada large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.3.4. Mexico
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Competitive Scenario
      • 9.3.4.3. Regulatory Framework
      • 9.3.4.4. Mexico large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.4. Europe
    • 9.4.1. Europe market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.2. UK
      • 9.4.2.1. Key Country Dynamics
      • 9.4.2.2. Competitive Scenario
      • 9.4.2.3. Regulatory Framework
      • 9.4.2.4. UK large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.3. Germany
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Competitive Scenario
      • 9.4.3.3. Regulatory Framework
      • 9.4.3.4. Germany large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.4. France
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Competitive Scenario
      • 9.4.4.3. Regulatory Framework
      • 9.4.4.4. France large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.5. Italy
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Competitive Scenario
      • 9.4.5.3. Regulatory Framework
      • 9.4.5.4. Italy large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.6. Spain
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Competitive Scenario
      • 9.4.6.3. Regulatory Framework
      • 9.4.6.4. Spain large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.7. Denmark
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Competitive Scenario
      • 9.4.7.3. Regulatory Framework
      • 9.4.7.4. Denmark large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.8. Sweden
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Competitive Scenario
      • 9.4.8.3. Regulatory Framework
      • 9.4.8.4. Sweden large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.4.9. Norway
      • 9.4.9.1. Key Country Dynamics
      • 9.4.9.2. Competitive Scenario
      • 9.4.9.3. Regulatory Framework
      • 9.4.9.4. Norway large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.5. Asia Pacific
    • 9.5.1. Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.2. Japan
      • 9.5.2.1. Key Country Dynamics
      • 9.5.2.2. Competitive Scenario
      • 9.5.2.3. Regulatory Framework
      • 9.5.2.4. Japan large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.3. China
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Competitive Scenario
      • 9.5.3.3. Regulatory Framework
      • 9.5.3.4. China large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.4. India
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Competitive Scenario
      • 9.5.4.3. Regulatory Framework
      • 9.5.4.4. India large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.5. Thailand
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Competitive Scenario
      • 9.5.5.3. Regulatory Framework
      • 9.5.5.4. Thailand large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.6. South Korea
      • 9.5.6.1. Key Country Dynamics
      • 9.5.6.2. Competitive Scenario
      • 9.5.6.3. Regulatory Framework
      • 9.5.6.4. South Korea large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.5.7. Australia
      • 9.5.7.1. Key Country Dynamics
      • 9.5.7.2. Competitive Scenario
      • 9.5.7.3. Regulatory Framework
      • 9.5.7.4. Australia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.6. Latin America
    • 9.6.1. Latin America market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.2. Brazil
      • 9.6.2.1. Key Country Dynamics
      • 9.6.2.2. Competitive Scenario
      • 9.6.2.3. Regulatory Framework
      • 9.6.2.4. Brazil large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.3. Argentina
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Competitive Scenario
      • 9.6.3.3. Regulatory Framework
      • 9.6.3.4. Argentina large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.6.4. Colombia
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Competitive Scenario
      • 9.6.4.3. Regulatory Framework
      • 9.6.4.4. Colombia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
  • 9.7. MEA
    • 9.7.1. MEA market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.2. South Africa
      • 9.7.2.1. Key Country Dynamics
      • 9.7.2.2. Competitive Scenario
      • 9.7.2.3. Regulatory Framework
      • 9.7.2.4. South Africa large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.3. Saudi Arabia
      • 9.7.3.1. Key Country Dynamics
      • 9.7.3.2. Competitive Scenario
      • 9.7.3.3. Regulatory Framework
      • 9.7.3.4. Saudi Arabia large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.4. UAE
      • 9.7.4.1. Key Country Dynamics
      • 9.7.4.2. Competitive Scenario
      • 9.7.4.3. Regulatory Framework
      • 9.7.4.4. UAE large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)
    • 9.7.5. Kuwait
      • 9.7.5.1. Key Country Dynamics
      • 9.7.5.2. Competitive Scenario
      • 9.7.5.3. Regulatory Framework
      • 9.7.5.4. Kuwait large molecule bioanalytical testing services market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Market Categorization
  • 10.2. Market Leaders
  • 10.3. Emerging Players
  • 10.4. Market Position Analysis, 2024
  • 10.5. Company Profiles
    • 10.5.1. Laboratory Corporation of America Holdings
      • 10.5.1.1. Company overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Service benchmarking
      • 10.5.1.4. Strategic initiatives
    • 10.5.2. IQVIA
      • 10.5.2.1. Company overview
      • 10.5.2.2. Financial performance
      • 10.5.2.3. Service benchmarking
      • 10.5.2.4. Strategic initiatives
    • 10.5.3. Syneous Health
      • 10.5.3.1. Company overview
      • 10.5.3.2. Financial performance
      • 10.5.3.3. Service benchmarking
      • 10.5.3.4. Strategic initiatives
    • 10.5.4. SGS, SA
      • 10.5.4.1. Company overview
      • 10.5.4.2. Financial performance
      • 10.5.4.3. Service benchmarking
      • 10.5.4.4. Strategic initiatives
    • 10.5.5. WuXi AppTec
      • 10.5.5.1. Company overview
      • 10.5.5.2. Financial performance
      • 10.5.5.3. Service benchmarking
      • 10.5.5.4. Strategic initiatives
    • 10.5.6. Intertek Plc
      • 10.5.6.1. Company overview
      • 10.5.6.2. Financial performance
      • 10.5.6.3. Service benchmarking
      • 10.5.6.4. Strategic initiatives
    • 10.5.7. Pace Analytical Services LLC
      • 10.5.7.1. Company overview
      • 10.5.7.2. Financial performance
      • 10.5.7.3. Service benchmarking
      • 10.5.7.4. Strategic initiatives
    • 10.5.8. ICON PLC
      • 10.5.8.1. Company overview
      • 10.5.8.2. Financial performance
      • 10.5.8.3. Service benchmarking
      • 10.5.8.4. Strategic initiatives
    • 10.5.9. Charles River Laboratories
      • 10.5.9.1. Company overview
      • 10.5.9.2. Financial performance
      • 10.5.9.3. Service benchmarking
      • 10.5.9.4. Strategic initiatives
    • 10.5.10. ThermoFisher Scientific
      • 10.5.10.1. Company overview
      • 10.5.10.2. Financial performance
      • 10.5.10.3. Service benchmarking
      • 10.5.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 4 Global Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 5 Global Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 6 Global Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 7 Global Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global Large Molecule Bioanalytical Testing Services, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 11 North America Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 12 North America Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 13 North America Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 14 North America Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 16 U.S. Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 17 U.S. Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 18 U.S. Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 19 U.S. Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 21 Canada Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 22 Canada Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 23 Canada Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 24 Canada Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Mexico Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 26 Mexico Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 27 Mexico Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 28 Mexico Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 29 Mexico Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 30 Europe Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 31 Europe Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 32 Europe Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 33 Europe Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 34 Europe Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 35 Europe Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 36 Germany Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 37 Germany Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 38 Germany Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 39 Germany Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 40 Germany Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 41 UK Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 42 UK Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 43 UK Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 44 UK Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 45 UK Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 46 France Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 47 France Large Molecule Bioanalytical Testing Services, by Source, 2018 - 2030 (USD Million)
  • Table 48 France Large Molecule Bioanalytical Testing Services, by Indication, 2018 - 2030 (USD Million)
  • Table 49 France Large Molecule Bioanalytical Testing Services, by Service Type, 2018 - 2030 (USD Million)
  • Table 50 France Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Italy Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 52 Italy Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 53 Italy Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 54 Italy Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 55 Italy Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Spain Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 57 Spain Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 58 Spain Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 59 Spain Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 60 Spain Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 62 Denmark Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 63 Denmark Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 64 Denmark Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 65 Denmark Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Sweden Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 67 Sweden Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 68 Sweden Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 69 Sweden Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 70 Sweden Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Norway Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 72 Norway Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 73 Norway Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 74 Norway Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 75 Norway Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 77 Asia Pacific Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 78 Asia Pacific Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 79 Asia Pacific Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 80 Asia Pacific Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 81 Asia Pacific Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 82 China Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 83 China Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 84 China Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 85 China Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 86 China Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 87 Japan Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 88 Japan Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 89 Japan Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 90 Japan Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 91 Japan Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 92 India Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 93 India Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 94 India Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 95 India Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 96 India Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 97 South Korea Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 98 South Korea Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 99 South Korea Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 100 South Korea Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 101 South Korea Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 102 Australia Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 103 Australia Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 104 Australia Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 105 Australia Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 106 Australia Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Thailand Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 108 Thailand Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 109 Thailand Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 110 Thailand Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 111 Thailand Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 112 Latin America Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 113 Latin America Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 114 Latin America Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 115 Latin America Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 116 Latin America Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 117 Latin America Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Brazil Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 119 Brazil Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 120 Brazil Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 121 Brazil Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 122 Brazil Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 124 Argentina Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 126 Argentina Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 127 Argentina Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 135 South Africa Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 137 South Africa Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 138 South Africa Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 145 UAE Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 146 UAE Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 147 UAE Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 148 UAE Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait Large Molecule Bioanalytical Testing Services, by Phase, 2018 - 2030 (USD Million)
  • Table 150 Kuwait Large Molecule Bioanalytical Testing Services, by Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait Large Molecule Bioanalytical Testing Services, by Test Type, 2018 - 2030 (USD Million)
  • Table 152 Kuwait Large Molecule Bioanalytical Testing Services, by Therapeutic Area, 2018 - 2030 (USD Million)
  • Table 153 Kuwait Large Molecule Bioanalytical Testing Services, by End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Large Molecule Bioanalytical Testing Services, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Regional Marketplace: Key Takeaways
  • Fig. 12 Global Large Molecule Bioanalytical Testing Services, for Preclinical, 2018 - 2030 (USD Million)
  • Fig. 13 Global Large Molecule Bioanalytical Testing Services, for With Antibody, 2018 - 2030 (USD Million)
  • Fig. 14 Global Large Molecule Bioanalytical Testing Services, for Without Antibody (ELISA Based Assay), 2018 - 2030 (USD Million)
  • Fig. 15 Global Large Molecule Bioanalytical Testing Services, for Clinical, 2018 - 2030 (USD Million)
  • Fig. 16 Global Large Molecule Bioanalytical Testing Services, for Pharmacokinetics, 2018 - 2030 (USD Million)
  • Fig. 17 Global Large Molecule Bioanalytical Testing Services, for ADA, 2018 - 2030 (USD Million)
  • Fig. 18 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 19 Global Large Molecule Bioanalytical Testing Services, for ADME, 2018 - 2030 (USD Million)
  • Fig. 20 Global Large Molecule Bioanalytical Testing Services, for PD, 2018 - 2030 (USD Million)
  • Fig. 21 Global Large Molecule Bioanalytical Testing Services, for Bioavailability, 2018 - 2030 (USD Million)
  • Fig. 22 Global Large Molecule Bioanalytical Testing Services, for Bioequivalence , 2018 - 2030 (USD Million)
  • Fig. 23 Global Large Molecule Bioanalytical Testing Services, for Other Tests, 2018 - 2030 (USD Million)
  • Fig. 24 Global Large Molecule Bioanalytical Testing Services, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 25 Global Large Molecule Bioanalytical Testing Services, for Infectious Diseases, 2018 - 2030 (USD Million)
  • Fig. 26 Global Large Molecule Bioanalytical Testing Services, for Cardiology, 2018 - 2030 (USD Million)
  • Fig. 27 Global Large Molecule Bioanalytical Testing Services, for Neurology, 2018 - 2030 (USD Million)
  • Fig. 28 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 29 Global Large Molecule Bioanalytical Testing Services, for SMEs, 2018 - 2030 (USD Million)
  • Fig. 30 Global Large Molecule Bioanalytical Testing Services, for CROs & CMOs, 2018 - 2030 (USD Million)
  • Fig. 31 Global Large Molecule Bioanalytical Testing Services, for Sponsor Organizations, 2018 - 2030 (USD Million)
  • Fig. 32 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 33 Global Large Molecule Bioanalytical Testing Services, for Large Firms, 2018 - 2030 (USD Million)
  • Fig. 34 Global Large Molecule Bioanalytical Testing Services, for CROs & CMOs, 2018 - 2030 (USD Million)
  • Fig. 35 Global Large Molecule Bioanalytical Testing Services, for Sponsor Organizations, 2018 - 2030 (USD Million)
  • Fig. 36 Global Large Molecule Bioanalytical Testing Services, for Others, 2018 - 2030 (USD Million)
  • Fig. 37 Regional Outlook, 2024 & 2030
  • Fig. 38 North America Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Mexico Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Europe Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 UK Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Germany Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 France Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Italy Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Spain Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Norway Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 India Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 China Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Japan Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Australia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Latin America Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Brazil Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Colombia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Middle East & Africa Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 South Africa Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Saudi Arabia Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 UAE Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Kuwait Large Molecule Bioanalytical Testing Services Market Estimates and Forecasts, 2018 - 2030 (USD Million)